Jared Scharf
CEO |
Desert Gold Ventures Inc.
Suite 210 - 9648-128th Street,
BC, V3T 2X9 Surrey (CAN)
jared.scharf@desertgold.ca
Desert Gold Ventures CEO Jared Scharf: Allied Gold, Barrick Gold and Endeavour Mining are important neighbors
April 9th, 2024
In today's interview, we have the opportunity to speak with the CEO of Desert Gold Ventures Inc. In recent years, Jared Scharf has expanded the company's land position in West Africa to 440 square kilometers and is located in the middle of the well-known gold companies Allied Gold, B2Gold, Barrick Gold and Endeavour Mining. The region in the West of Mali is one of the most important gold districts in the world and guarantees secure income for the state and a large number of different jobs for the population.
Dennis Karp
Executive Chairman |
Manuka Resources Limited
201-207 Kent Street,
2000 Sydney, NSW (AU)
admin@manukaresources.com.au
Manuka Resources Executive Chairman Dennis Karp on the potential in New Zealand after the change of government
January 31st, 2024
Manuka Resources Limited is an Australian mining and exploration company with significant assets in the Cobar Basin in mid-western New South Wales. In addition to the November 2022 acquisition of Trans-Tasman Resources Limited (TTR), the owner of the VTM Taranaki Iron Sands Project, the company also holds all rights to two fully permitted mining projects, a gold project and a silver project, both located in the Cobar Basin. Due to a change of government in New Zealand, the TTR project has come under the spotlight. We find out more in an interview.
David Elsley
CEO |
Cardiol Therapeutics Inc.
2265 Upper Middle Road East, 602,
L6H 0G5 Oakville, Ontario (CAN)
info@cardiolrx.com
+1 (289) 910-0850
Cardiol Therapeutics Inc. CEO David Elsley on new therapies for acute myocarditis and recurrent pericarditis
January 30th, 2024
Cardiol Therapeutics Inc. is a clinical-stage life sciences company focused on the research and clinical development of anti-inflammatory and anti-fibrotic therapies for the treatment of heart disease. The Company’s lead small molecule drug candidate, CardiolRx™ (cannabidiol) oral solution, is pharmaceutically manufactured and in clinical development for use in the treatment of heart disease. It is recognized that cannabidiol inhibits activation of the inflammasome pathway, an intracellular process known to play an important role in the development and progression of inflammation and fibrosis associated with myocarditis, pericarditis, and heart failure.
Craig Taylor
CEO |
Defense Metals Corp.
228-1122 Mainland Street,
V6B 5L1 Vancouver, BC (CAN)
craig@defensemetals.com
Defense Metals Corp. CEO Craig Taylor on the potential of the Rare Earth project
January 11th, 2024
Defense Metals Corp. is a mineral exploration and development company focused on the development of its 100% owned Wicheeda Rare Earth Element Deposit located near Prince George, British Columbia, Canada. Defense Metals Corp. trades on the TSX Venture Exchange under the symbol “DEFN”, in the United States, trading symbol “DFMTF” on the OTCQB and in Germany on the Frankfurt Exchange and other platforms under “35D”. We have the opportunity to talk to the CEO and get first-hand information.
James Tansey
CEO |
Klimat X Developments Inc.
800 West Pender Street,
V6C 2V6 Vancouver (CAN)
info@klimatx.com
1-778-373-3736
Interview with Klimat X: "The market for CO2 certificates could increase tenfold by 2030"
September 14th, 2023
In 2010, James Tansey played a crucial role in making the Vancouver Olympics carbon-neutral. After that, the environmental scientist worked as a professor and advised affluent clients on sustainable investments. James also helped establish the Great Bear Rainforest carbon project in the temperate rainforests of British Columbia, which protects 6.4m hectares of rainforest and benefits the First Nations communities. Today, Tansey is CEO of Klimat X. The Company protects forests and mangrove areas to generate carbon credits. In this interview, Tansey explains how the business model works, how the Klimat X team is able to convince potential investors with facts and figures on climate change solutions, and why the CEO believes his company is excellently positioned to benefit from the exorbitant growth of the CO2 certificate market.
Terry Lynch
CEO |
Power Nickel
82 Richmond St East Suite 202,
M5C 1P1 Toronto (CAN)
info@powernickel.com
+1 416 900-5445
Interview Power Nickel: "The market has not yet come close to realizing the new potential"
September 6th, 2023
Power Nickel stands for NISK, a promising nickel project in Quebec, Canada. Recently, the Company entered into an extensive partnership with the nickel specialist CVMR Corp. Power Nickel CEO Terry Lynch explains how his Company can benefit from the deal in the short term, why new options along the value chain are realistic for Power Nickel, and why, in his opinion, the stock is far from being fairly valued.
Interview with Cannabis Trader Cantourage: "Can grow dynamically in any legal framework"
August 23rd, 2023
Legal cannabis consumption in Germany is a done deal. Last year, the German cannabis hopeful Cantourage made a spectacular debut on the stock market. For the coming quarters, the Berlin-based company anticipates high double-digit sales growth. In this interview, Philip Schetter, CEO of Cantourage, discusses his company's unique selling points. He explains why obtaining cannabis from a pharmacy will soon be as simple as getting Ibuprofen and why hobby gardeners are not necessarily competition for Cantourage. In addition: what mistake Canadian cannabis company Cantourage will not make under any circumstances.
Sébastien Plouffe
CEO |
Defence Therapeutics Inc.
1680 – 200 Burrard Street,
V6C 3L6 Vancouver (CAN)
info@defencetherapeutics.com
+1 (514) 947 – 2272
Interview Defence Therapeutics: "The next six months will be trend-setting."
July 26th, 2023
Two Phase I trials against cancer before the end of the year are planned, plus crucial results from a comparative study around mRNA vaccines and a lively collaboration with French nuclear group Orano - cancer pioneer Defence Therapeutics is dancing on many highs. Sébastien Plouffe, CEO of Defence Therapeutics, reveals in an interview how the Canadian company manages to advance so many projects in parallel, what will be important in the coming months, and how the biotech intends to accelerate its development.
John Passalacqua
CEO and Director |
First Phosphate Corp.
1055 West Georgia Street,
1500 Royal Centre Vancouver (CAN)
questions@firstphosphate.com
Interview First Phosphate: "We are breaking new ground in processes and ESG"
March 22nd, 2023
Lithium iron phosphate batteries have become widely used in e-cars. Currently, China dominates the phosphate market and mines and processes the material in a way that is anything but environmentally friendly. First Phosphate relies on high grades and state-of-the-art strategy to cover large parts of the phosphate value chain. John Passalacqua, CEO and Director of First Phosphate, explains the framework and key data and shows why First Phosphate's plans are almost unique.
Frederick Kozak
President and CEO |
Auxico Resources Canada Inc.
201 Notre Dame West, Suite 500,
H2Y 1T4 Montreal (CAN)
ta@auxicoresources.com
+1 514-296-1641
Interview with rare earths company Auxico Resources: "We are solving the problem of dependence on China today."
December 27th, 2022
Auxico Resources has three promising rare earth projects and potential for cash flows across multiple jurisdictions. In the interview, President and CEO Frederick Kozak explains how the Company plans to generate even more revenue as early as 2023, how existing partnerships will help on the road to production, and why Auxico Resources sees itself as a solution provider around the climate and energy transition.
André Kolbinger
CEO |
Smartbroker Holding AG
Ritterstraße 11,
10969 Berlin (DE)
ir@smartbroker-holding.de
+49 (0)30 20 456 500
Interview Smartbroker: On new paths to old goals
December 9th, 2022
With the Smartbroker 2.0 project, the Berlin-based company wanted to set the course for a golden future. The plan to develop large parts of the brokerage backend itself has been shelved, and the Company has introduced a new partner - Baader Bank. In this interview, find out what the new direction will mean for customers and shareholders and why Smartbroker CEO André Kolbinger announces "hard work and less talk" for 2023.
Uwe Ahrens
Direktor |
Altech Advanced Materials AG
Ziegelhäuser Landstraße 3,
69120 Heidelberg (DE)
info@altechadvancedmaterials.com
Interview with battery pioneer Altech Advanced Materials: "We hit a nerve with potential partners and investors"
October 6th, 2022
Cheaper, safer, better: Altech Advanced Materials has so far convinced the market with the attributes of its anode technology. Since September 2022, it has been clear that the Company also has well-developed ideas around stationary energy storage and wants to lead the Fraunhofer Institute's solid-state battery technology to market maturity together with the researchers. In an interview, Altech CEO Uwe Ahrens talks about the three business areas, the path to production and the special features of his Company.